Journal: Oncotarget
Article Title: DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling
doi:
Figure Lengend Snippet: Western blot to evaluate cell cycle related protein expressions (A) and protein abundance of Wnt/β-catenin pathway (B) . Analysis of GEO database shows correlation between DACH1 and β-catenin downstream targets Nr-CAM (C) , DKK1 (D) , PTTG1 (E) and SOX9 (F) by one-way ANOVA test.
Article Snippet: The primary antibodies used were rabbit polyclone DACH1 (ProteinTech group), β-catenin (ProteinTech group), phosph-β-catenin (Santa Cruz), GSK3β (ProteinTech group), phosph-GSK3β (Santa Cruz), cyclin D1 (Cell Signaling Technology), β-actin (Cell Signaling Technology), CDK4 (Santa Cruz), cyclin B1 (Santa Cruz), cyclin E1 (Santa Cruz), PCNA (Santa Cruz) and α-vinculin (Sigma).
Techniques: Western Blot, Quantitative Proteomics